Samnir Adverse Reactions

Adverse effects usually are transient and mild in severity. The adverse effects that may be occurred are diarrhea, rash, vomiting, skin candida, abdominal pain, leucopenia, vulvovaginal candidiasis, vaginal infection, dyspepsia, hyperkinesia, increase in AST, maculopapular rash, nausea. In addition, adverse effects may be occurred: Lymphocytes increased/decreased, alkaline phosphatase increased, bicarbonate decreased, eosinophils increased, lactate dehydrogenase increased, platelets increased, polymorphonuclear neutrophils increased/decreased, proteinuria, Stevens-Johnson syndrome, conjunctivitis, toxic epidermal necrolysis, stomatitis, erythema multiforme, fulminant hepatitis, cholestasis, hepatitis (acute), granulocytes decreased, melaena, hepatic failure, jaundice, anaphylactic shock, face and laryngeal edema, exfoliative dermatitis, suffocation feeling, enterocolitis (acute), bloody stool, pseudomembranous colitis, pancytopenia, pneumonia (drug-induced), hemolytic anemia, thrombocytopenia, fever, chest pain, respiratory failure, asthma, renal failure (acute), haemorrhagic diathesis, coagulopathy, peptic ulcer, loss of consciousness, cardiac failure, hypertension, myocardial infarction, involuntary movement, rhabdomyolysis.
NOTE: The administration of Cefdinir may result in a false-positive reaction for ketones in the urine with tests using nitroprusside. A false-positive reaction for glucose in the urine may occur with tests using some diagnostic test kits, Benedict's solution, or Fehling's solution. Including, a false-positive results may occur in the direct Coombs' test.
If any abnormal symptoms are observed, SAMNIR should be discontinued and appropriate dose adjustment should be taken.